First-line chemotherapy for non-small-cell lung cancer: Is there a superior regimen based on histology?

被引：44
|
作者：
Einhorn, Lawrence H. [1 ]
机构：
[1] Indiana Univ, Dept Med, Div Hematol Oncol, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 21期
关键词：
D O I：
10.1200/JCO.2008.17.2056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3485 / 3486
页数：2
相关论文
共 50 条
  • [41] First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors
    Olivier Bylicki
    Helene Barazzutti
    Nicolas Paleiron
    Jacques Margery
    Jean-Baptiste Assié
    Christos Chouaïd
    BioDrugs, 2019, 33 : 159 - 171
  • [42] Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China
    Xiang, Guiyuan
    Gu, Lingna
    Chen, Xuan
    Wang, Fan
    Chen, Bohua
    Zhao, Jie
    Lu, Yun
    Chang, Feng
    Zhu, Yumei
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [43] EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer
    Kao, Hsiang-Fong
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    FUTURE ONCOLOGY, 2013, 9 (07) : 991 - 1003
  • [44] Afatinib: A first-line treatment for selected patients with metastatic non-small-cell lung cancer
    Engle, Jeff
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (22) : 1933 - 1938
  • [45] Osimertinib as First-Line Treatment in EGFR-Mutated Non-Small-Cell Lung Cancer
    Popat, Sanjay
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02): : 192 - 193
  • [46] First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer
    Mengato, Daniele
    Cancanelli, Luca
    Rivano, Melania
    Chiumente, Marco
    Di Spazio, Lorenzo
    Messori, Andrea
    IMMUNOTHERAPY, 2022, 14 (11) : 871 - 877
  • [47] Costs of First-Line Doublet Chemotherapy and Lifetime Medical Care in Advanced Non-small-Cell Lung Cancer in the United States
    Lang, Kathleen
    Marciniak, Martin D.
    Faries, Douglas
    Stokes, Michael
    Buesching, Don
    Earle, Craig
    Treat, Joseph
    Babineaux, Steve
    Morissette, Nathalie
    Thompson, David
    VALUE IN HEALTH, 2009, 12 (04) : 481 - 488
  • [48] First-line PD-1 Inhibitors and Chemotherapy Combined with or without Radiotherapy in Advanced Non-small-cell Lung Cancer
    Ding, P.
    Huang, Y.
    Tong, F.
    Chen, L.
    Wen, L.
    Zhang, R.
    Cheng, S.
    Dong, X.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S75 - S75
  • [49] EFFICACY AND SAFETY OF DOCETAXEL PLUS OXALIPLATIN AS A FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER
    Ban, Heejung
    Rang, Hyun-wook
    Kim, Woo-jin
    Park, Chan-woo
    Oh, In-jae
    Rini, Kyu-sik
    Kim, Young-chul
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
  • [50] The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials
    Noonan, Krista L.
    Ho, Cheryl
    Laskin, Janessa
    Murray, Nevin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (11) : 1523 - 1531
12345